Analysts Lift Visa, CTSH and MSFT Targets
Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish
Wells Fargo made two bold moves on Monday. Analyst Jason Kupferberg raised his target on CTSH to $77 from $67 and kept a Buy rating. On the same note, he lifted ACN to $252 from $210, retaining a Hold. Both IT services names saw the consensus target price nudge higher.
Susquehanna's James Friedman set a $480 target on V, up from $427, citing a continued Buy. That is a 12.4% jump in his price view and sits well above the current consensus of $427.
MSFT saw its average analyst target tick up to $603.24 from $601.73 as the consensus held at 54 Buy ratings and just three Holds.
Piper Sandler's Edward Tenthoff raised his target on MRNA sharply to $230 from $167, keeping a Buy. That 38% target hike is one of the most aggressive single moves of the day.
On the bearish side, CMCSA and DXCM both saw consensus targets trimmed. Comcast's average slipped to $27.98 from $28.16, keeping four Sell ratings in place. DexCom's target edged down to $96.19 from $96.46.
LITE received a new recommendation, with consensus sitting at 23 Buys. ORLY also drew a new coverage initiation, landing with 23 Buy ratings, though one recommendation was pulled from the pool.
EFX rounded out the day's activity with a consensus target lift to $200.35 from $199, reflecting stable Buy-heavy coverage across 17 analysts.
Stocks in this article
How this article was generated
- Generated
- 26 Oct 2026, 16:20
- Prompt version
- v1.0
- Data sources
- Analyst consensusAlt DataIndex Rebalance
ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.